Cargando…
PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study
OBJECTIVES: To comprehensively classify interventions performed by emergency medicine clinical pharmacists and quantify cost avoidance generated through their accepted interventions. DESIGN: A multicenter, prospective, observational study was performed between August 2018 and January 2019. SETTING:...
Autores principales: | Rech, Megan A., Adams, William, Smetana, Keaton S., Gurnani, Payal K., Van Berkel Patel, Megan A., Peppard, William J., Hammond, Drayton A., Flannery, Alexander H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078282/ https://www.ncbi.nlm.nih.gov/pubmed/33912836 http://dx.doi.org/10.1097/CCE.0000000000000406 |
Ejemplares similares
-
PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study
por: Rech, Megan A., et al.
Publicado: (2021) -
Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics: PHARM-PEDS Study
por: Kiskaddon, Amy L., et al.
Publicado: (2023) -
International Survey of Thrombolytic Use for Treatment of Cardiac Arrest Due to Massive Pulmonary Embolism
por: Rech, Megan A., et al.
Publicado: (2020) -
Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
por: Rech, Megan A., et al.
Publicado: (2021) -
Balanced Crystalloids in Sepsis: Are We There Yet?
por: Hammond, Drayton A., et al.
Publicado: (2020)